Tender offer period for DNA shares runs through 26 September

(Fornebu, 23 September 2019) On August 29, Telenor launched a mandatory public tender offer for all of the remaining issued and outstanding shares in Finnish telecommunications company, DNA. The offer period ends on 26 September 2019.*

Published: 23 September 2019 12:02

Reading Time: 1 minute

In the tender offer, DNA’s shareholders are offered a cash consideration of EUR 20.90 for each share. The offer price represents a premium of 7.4% compared to the closing share price on 8 April 2019 and a 21.3% premium compared to the three-month volume weighted average share price preceding 9 April 2019 (adjusted for dividend**).

The Board of Directors of DNA, acting through its independent members, unanimously recommends that the shareholders of DNA accept the tender offer.

More information can be found on the DNA Mandatory Tender Offer webpage.

*The offeror reserves the right to extend the offer period.
**DNA cash dividend of EUR 1.10 per share has been adjusted for 8 January 2019 – 28 March 2019.

For general questions for Telenor Investor Relations
Øystein Myrvold
Telenor Group Head of Investor Relations
oystein.myrvold@telenor.com
+47 9923 04 60

Press contact
Jonathan Higgins
Director, Financial Communications
Jonathan.higgins@telenor.com
+47 901 10 606